Skip to main content
Figure 1 | BMC Cancer

Figure 1

From: A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France

Figure 1

Decision curve analysis. The dashed line is for the base model (age, DRE result, and total PSA); the solid line is for the full model (age, DRE result, total PSA, free PSA, intact PSA, and hK2). As a comparison, the thin grey line is for the strategy of biopsying all men and the thick black line for biopsying no man.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us